News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,758 Results
Type
Article (51412)
Company Profile (296)
Press Release (713036)
Multimedia
Podcasts (103)
Webinars (20)
Section
Business (212950)
Career Advice (2121)
Deals (36675)
Drug Delivery (130)
Drug Development (84086)
Employer Resources (174)
FDA (17297)
Job Trends (15827)
News (360882)
Policy (34933)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2814)
Accelerated approval (42)
Adcomms (30)
Allergies (166)
Alliances (51775)
ALS (199)
Alzheimer's disease (1809)
Antibody-drug conjugate (ADC) (378)
Approvals (17609)
Artificial intelligence (631)
Autoimmune disease (231)
Automation (51)
Bankruptcy (375)
Best Places to Work (12096)
BIOSECURE Act (20)
Biosimilars (203)
Biotechnology (190)
Bladder cancer (179)
Brain cancer (66)
Breast cancer (705)
Cancer (5429)
Cardiovascular disease (464)
Career advice (1805)
Career pathing (42)
CAR-T (304)
CDC (59)
Celiac Disease (2)
Cell therapy (812)
Cervical cancer (43)
Clinical research (72250)
Collaboration (1958)
Company closure (4)
Compensation (1279)
Complete response letters (72)
COVID-19 (2856)
CRISPR (100)
C-suite (1012)
Cystic fibrosis (149)
Data (7134)
Decentralized trials (3)
Denatured (38)
Depression (163)
Dermatology (58)
Diabetes (563)
Diagnostics (7052)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (297)
Drug pricing (205)
Drug shortages (32)
Duchenne muscular dystrophy (269)
Earnings (93271)
Editorial (65)
Employer branding (21)
Employer resources (153)
Events (123541)
Executive appointments (1060)
FDA (20803)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1655)
Gene editing (216)
Generative AI (59)
Gene therapy (667)
GLP-1 (1084)
Government (4983)
Grass and pollen (6)
Guidances (398)
Healthcare (20011)
HIV (75)
Huntington's disease (53)
IgA nephropathy (91)
Immunology and inflammation (279)
Immuno-oncology (83)
Indications (158)
Infectious disease (3179)
Inflammatory bowel disease (209)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (275)
Interviews (324)
IPO (17019)
IRA (51)
Job creations (4060)
Job search strategy (1509)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (574)
Leadership (36)
Legal (8510)
Liver cancer (103)
Longevity (29)
Lung cancer (734)
Lymphoma (409)
Machine learning (53)
Management (59)
Manufacturing (939)
MASH (183)
Medical device (14889)
Medtech (14971)
Mergers & acquisitions (20825)
Metabolic disorders (1467)
mRNA (185)
Multiple sclerosis (174)
NASH (17)
Neurodegenerative disease (400)
Neuropsychiatric disorders (103)
Neuroscience (3246)
Neurotech (1)
NextGen: Class of 2026 (6924)
Non-profit (4787)
Now hiring (73)
Obesity (697)
Opinion (293)
Ovarian cancer (187)
Pain (234)
Pancreatic cancer (261)
Parkinson's disease (350)
Partnered (34)
Patents (558)
Patient recruitment (607)
Peanut (62)
People (62160)
Pharmaceutical (65)
Pharmacy benefit managers (33)
Phase 1 (22493)
Phase 2 (31734)
Phase 3 (23699)
Pipeline (7192)
Policy (313)
Postmarket research (2742)
Preclinical (9571)
Press Release (67)
Prostate cancer (282)
Psychedelics (52)
Radiopharmaceuticals (313)
Rare diseases (1020)
Real estate (6358)
Recruiting (70)
Regulatory (26473)
Reports (54)
Research institute (2572)
Resumes & cover letters (363)
Rett syndrome (32)
RNA editing (17)
RSV (88)
Schizophrenia (171)
Series A (272)
Series B (205)
Service/supplier (12)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (169)
Sponsored (47)
Startups (3882)
State (2)
Stomach cancer (19)
Supply chain (122)
Tariffs (88)
The Weekly (63)
Vaccines (1107)
Venture capital (101)
Weight loss (459)
Women's health (114)
Worklife (19)
Date
Today (58)
Last 7 days (652)
Last 30 days (2723)
Last 365 days (30649)
2026 (8175)
2025 (30910)
2024 (36107)
2023 (41150)
2022 (52385)
2021 (57102)
2020 (55916)
2019 (48800)
2018 (36946)
2017 (33749)
2016 (33575)
2015 (39617)
2014 (33328)
2013 (28568)
2012 (30857)
2011 (31558)
2010 (29926)
Location
Africa (816)
Alabama (92)
Alaska (7)
Arizona (341)
Arkansas (15)
Asia (42703)
Australia (7034)
California (12381)
Canada (3530)
China (1279)
Colorado (539)
Connecticut (542)
Delaware (373)
Europe (93034)
Florida (1864)
Georgia (404)
Hawaii (3)
Idaho (66)
Illinois (1015)
India (81)
Indiana (567)
Iowa (22)
Japan (495)
Kansas (132)
Kentucky (46)
Louisiana (39)
Maine (73)
Maryland (1531)
Massachusetts (8927)
Michigan (358)
Minnesota (702)
Mississippi (7)
Missouri (141)
Montana (33)
Nebraska (29)
Nevada (140)
New Hampshire (88)
New Jersey (3330)
New Mexico (30)
New York (3280)
North Carolina (1642)
North Dakota (8)
Northern California (6108)
Ohio (368)
Oklahoma (23)
Oregon (42)
Pennsylvania (2504)
Puerto Rico (26)
Rhode Island (52)
South America (1202)
South Carolina (78)
South Dakota (1)
Southern California (4867)
Tennessee (203)
Texas (1966)
United States (44275)
Utah (372)
Vermont (1)
Virginia (297)
Washington D.C. (83)
Washington State (1019)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
764,758 Results for "fuse medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fuse Oncology Announces Partnership With Elekta
June 19, 2025
·
1 min read
Lone Star Bio
Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results
On August 14, 2023, Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its quarterly report on Form 10-Q for the quarter ended June 30, 2023 with the Securities and Exchange Commission (“SEC”).
August 15, 2023
·
10 min read
Lone Star Bio
Fuse Medical, Inc. Fiscal Year 2022 Financial Results
Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its annual report on Form 10-K for the year ended December 31, 2022 with the Securities and Exchange Commission (“SEC”) on April 14, 2023.
April 18, 2023
·
11 min read
Press Releases
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
March 30, 2026
·
7 min read
Press Releases
Fuse Oncology Establishes Clinical Liaison Council
March 10, 2025
·
2 min read
Press Releases
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
March 3, 2026
·
1 min read
Press Releases
Medical Care Technologies Inc. (OTC PINK:MDCE) Reports 63% Revenue Growth, Strong Profitability, and Significant Cash Flow Improvement in 2025
March 26, 2026
·
3 min read
Press Releases
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
March 24, 2026
·
6 min read
Press Releases
Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors
February 26, 2026
·
8 min read
Press Releases
Vivani Medical, Inc. Announces Closing of Common Stock Offering
January 28, 2026
·
5 min read
1 of 76,476
Next
